Lemaitre Vascular (LMAT) Net Cash Flow (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Net Cash Flow for 17 consecutive years, with -$165000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 114.01% year-over-year to -$165000.0 in Q2 2026; TTM through Jun 2026 was -$300000.0, a 107.04% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 15.95% from the prior year.
• Net Cash Flow was -$165000.0 for Q2 2026 at Lemaitre Vascular, up from -$1.2 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $5.8 million in Q4 2023 and troughed at -$4.2 million in Q2 2024.
• A 5-year average of $730111.1 and a median of $506500.0 in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow jumped 378.38% in 2022 and plunged 253.58% in 2024, its largest moves.
• Over 5 years, Net Cash Flow stood at $1.6 million in 2022, then surged by 273.41% to $5.8 million in 2023, then slipped by 7.38% to $5.4 million in 2024, then sank by 48.89% to $2.7 million in 2025, then tumbled by 106.01% to -$165000.0 in 2026.
• The last three Net Cash Flow figures came in at -$165000.0 (Q2 2026), -$1.2 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.